These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 9052584)
1. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol. O'Brien JE; Dvorin E; Drugan A; Johnson MP; Yaron Y; Evans MI Obstet Gynecol; 1997 Mar; 89(3):355-8. PubMed ID: 9052584 [TBL] [Abstract][Full Text] [Related]
2. Unexplained elevated midtrimester maternal serum levels of alpha fetoprotein, human chorionic gonadotropin, or low unconjugated estriol: recurrence risk and association with adverse perinatal outcome. Wax JR; Lopes AM; Benn PA; Lerer T; Steinfeld JD; Ingardia CJ J Matern Fetal Med; 2000; 9(3):161-4. PubMed ID: 10914623 [TBL] [Abstract][Full Text] [Related]
3. Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening. Palomaki GE; Knight GJ; Haddow JE; Canick JA; Wald NJ; Kennard A Obstet Gynecol; 1993 May; 81(5 ( Pt 1)):675-8. PubMed ID: 7682315 [TBL] [Abstract][Full Text] [Related]
4. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]
5. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects. Saller DN; Canick JA; Palomaki GE; Knight GJ; Haddow JE Obstet Gynecol; 1994 Nov; 84(5):852-5. PubMed ID: 7524003 [TBL] [Abstract][Full Text] [Related]
6. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns. Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738 [TBL] [Abstract][Full Text] [Related]
7. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein. Benn PA; Horne D; Briganti S; Rodis JF; Clive JM Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527 [TBL] [Abstract][Full Text] [Related]
8. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction. Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282 [TBL] [Abstract][Full Text] [Related]
9. Second-trimester maternal serum screening for Down syndrome in in vitro fertilization pregnancies. Rice JD; McIntosh SF; Halstead AC Prenat Diagn; 2005 Mar; 25(3):234-8. PubMed ID: 15791658 [TBL] [Abstract][Full Text] [Related]
10. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)? Sancken U; Bartels I Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279 [TBL] [Abstract][Full Text] [Related]
12. Medians for second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups. Benn PA; Clive JM; Collins R Clin Chem; 1997 Feb; 43(2):333-7. PubMed ID: 9023136 [TBL] [Abstract][Full Text] [Related]
13. Maternal serum triple marker levels in immigrants to Israel from Ethiopia. Sharony R; Itzhaky D; Amiel A; Fejgin M; Cuckle H Fetal Diagn Ther; 2009; 26(4):200-2. PubMed ID: 19940445 [TBL] [Abstract][Full Text] [Related]
14. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy]. Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094 [TBL] [Abstract][Full Text] [Related]
15. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels. Cowans NJ; Spencer K Prenat Diagn; 2005 Aug; 25(8):693-9. PubMed ID: 16050001 [TBL] [Abstract][Full Text] [Related]
16. Different median levels of serum triple markers in the second trimester of pregnancy in a Thai Ethnic Group. Wanapirak C; Sirichotiyakul S; Luewan S; Yanase Y; Traisrisilp K; Tongsong T J Obstet Gynaecol Res; 2012 Apr; 38(4):686-91. PubMed ID: 22380630 [TBL] [Abstract][Full Text] [Related]
18. The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome. Christiansen M; Høgdall EV; Larsen SO; Høgdall C Prenat Diagn; 2002 May; 22(5):385-7. PubMed ID: 12001192 [TBL] [Abstract][Full Text] [Related]
19. Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy. Palomaki GE; Neveux LM; Haddow JE; Wyatt P Prenat Diagn; 2007 Sep; 27(9):808-13. PubMed ID: 17590886 [TBL] [Abstract][Full Text] [Related]
20. Evaluating the thresholds of abnormal second trimester multiple marker screening tests associated with intra-uterine growth restriction. Odibo AO; Sehdev HM; Stamilio DM; Macones GA Am J Perinatol; 2006 Aug; 23(6):363-7. PubMed ID: 16841275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]